Global eClinical solutions provider Mednet and data-focused contract research organisation (CRO) Bioforum have formed a strategic partnership to optimise the efficiency and flexibility of clinical trials.
The new partnership, formed as part of the Mednet Value Program (MVP), will provide the CRO with access to Mednet’s Cloud-based eClinical platform.
Mednet designed MVP to provide additional services and benefits that support and add value to CROs and other types of partners.
Under the partnership, Bioforum will also make use of Mednet’s concierge-level account management and service delivery, advanced certification, and other mentoring offerings.
Mednet global partnerships vice-president Scott Robertson said: “We’re thrilled to have Bioforum as part of the Mednet Value Program, and we look forward to working with them to provide additional value to their customers.
“We believe our highly flexible and comprehensive all-in-one eClinical solution will enable Bioforum to effectively leverage their extensive data capture and analysis experience to accelerate clinical development and help life sciences sponsors achieve their goals.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe Mednet platform provides comprehensive and flexible eClinical solutions to research organisations. It allows them to execute clinical trials and address new challenges across the sector effectively.
Bioforum president and co-founder Amir Malka said: “We’re excited to partner with Mednet and looking forward to working together to bring our teams’ broad and deep clinical trials expertise to study sponsors, along with a highly flexible and efficient platform that will enable them to swiftly adapt to a variety of study protocols and types.”